40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
168.96%
Revenue growth above 1.5x AR's 41.96%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
2212.00%
Gross profit growth above 1.5x AR's 129.03%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
129.91%
EBIT growth 75-90% of AR's 152.52%. Bill Ackman would push for cost reforms or better product mix to narrow the gap.
129.91%
Operating income growth at 75-90% of AR's 152.52%. Bill Ackman would demand a plan to enhance operating leverage.
152.75%
Net income growth comparable to AR's 139.96%. Walter Schloss might see both following similar market or cost trajectories.
152.11%
EPS growth 1.25-1.5x AR's 136.79%. Bruce Berkowitz would check if strategic initiatives like cost cutting or better capital management explain the difference.
152.26%
Diluted EPS growth 1.25-1.5x AR's 136.32%. Bruce Berkowitz would verify if strategic moves (e.g., targeted acquisitions, cost cuts) explain the edge.
1.40%
Share reduction more than 1.5x AR's 9.08%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.99%
Diluted share reduction more than 1.5x AR's 9.54%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
16.55%
Dividend growth of 16.55% while AR is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
124.10%
OCF growth above 1.5x AR's 37.08%. David Dodd would confirm a clear edge in underlying cash generation.
85.61%
Positive FCF growth while AR is negative. John Neff would see a strong competitive edge in net cash generation.
-76.47%
Negative 10Y revenue/share CAGR while AR stands at 518.16%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-64.31%
Negative 5Y CAGR while AR stands at 518.16%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-39.50%
Negative 3Y CAGR while AR stands at 86.32%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-89.40%
Negative 10Y OCF/share CAGR while AR stands at 330.38%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-88.07%
Negative 5Y OCF/share CAGR while AR is at 330.38%. Joel Greenblatt would question the firm’s operational model or cost structure.
-82.89%
Negative 3Y OCF/share CAGR while AR stands at 98.68%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-78.00%
Negative 10Y net income/share CAGR while AR is at 258.21%. Joel Greenblatt sees a major red flag in long-term profit erosion.
126.62%
Below 50% of AR's 258.21%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
45.04%
3Y net income/share CAGR 50-75% of AR's 67.09%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
-68.23%
Negative equity/share CAGR over 10 years while AR stands at 231.95%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-67.75%
Negative 5Y equity/share growth while AR is at 231.95%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-0.97%
Negative 3Y equity/share growth while AR is at 197.12%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-84.68%
Cut dividends over 10 years while AR stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-92.41%
Negative 5Y dividend/share CAGR while AR stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-89.55%
Negative near-term dividend growth while AR invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
50.63%
AR growth well above AR's 24.80%. Michael Burry fears inflated revenue or higher default risk in the near future.
No Data
No Data available this quarter, please select a different quarter.
-2.34%
Negative asset growth while AR invests at 7.90%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
25.25%
Positive BV/share change while AR is negative. John Neff sees a clear edge over a competitor losing equity.
-20.74%
We’re deleveraging while AR stands at 12.16%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-3.93%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.